New Hope, PA, United States of America

John D Lipani


Average Co-Inventor Count = 1.1

ph-index = 5

Forward Citations = 109(Granted Patents)


Location History:

  • Fountain Hills, AZ (US) (2011)
  • New Hope, PA (US) (2014 - 2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by John Lipani: Pioneering Biochip Technology

Introduction

John Lipani is an inventive mind based in Fountain Hills, AZ, who has contributed to the field of biotechnology. With a focus on biochips, his work has significant implications in drug development and efficacy evaluation.

Latest Patents

Lipani holds one patent titled "Biochips and method of screening using drug induced gene and protein expression profiling." This innovative patent provides a biochip microarray designed for the identification of gene and protein induction or repression by drugs. It enhances the evaluation of drug efficacy and toxicity, offering predictive insights into newly-discovered drugs. The experimental data acquired from the biochip is integrated into a Drug-Gene-Protein-Biology (DGPB) database, facilitating data mining and analysis configured to user preferences. Moreover, the patent describes a method for predicting the effects of test compositions in treating diseases, utilizing a biochip array and an animal model to generate biological markers that assist in evaluating treatment effectiveness.

Career Highlights

John Lipani is associated with Mowycal Lending, LLC, where his expertise in biotechnology finds practical application. His innovative approach in developing biochips has enhanced the capabilities of drug screening processes.

Collaborations

In his professional journey, Lipani collaborates with Garrett W. Lindemann, contributing shared insights and expertise within the biotechnology sector.

Conclusion

John Lipani is a remarkable inventor whose dedication to the realm of biochips and drug evaluation continues to pave new paths in biotechnology. His innovative patent and collaborations mark him as a key figure in advancing methods that improve drug development and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…